Banco Bilbao Vizcaya Argentaria’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-997
Closed -$245K 741
2022
Q3
$245K Sell
997
-9
-0.9% -$2.43K ﹤0.01% 679
2022
Q2
$249K Sell
1,006
-394
-28% -$106K ﹤0.01% 658
2022
Q1
$460K Sell
1,400
-139
-9% -$42.8K 0.01% 598
2021
Q4
$557K Sell
1,539
-2,796
-64% -$945K 0.01% 651
2021
Q3
$1.41M Sell
4,335
-1,611
-27% -$546K 0.02% 452
2021
Q2
$1.76M Buy
5,946
+1,309
+28% +$402K 0.03% 410
2021
Q1
$1.47M Buy
4,637
+561
+14% +$180K 0.03% 421
2020
Q4
$1.32M Buy
4,076
+1,803
+79% +$499K 0.03% 420
2020
Q3
$629K Sell
2,273
-191
-8% -$55K 0.02% 501
2020
Q2
$595K Sell
2,464
-113
-4% -$22.7K 0.02% 521
2020
Q1
$374K Buy
2,577
+635
+33% +$105K 0.01% 535
2019
Q4
$331K Buy
+1,942
New +$360K 0.01% 595

Other funds holding ABMD

Banco Bilbao Vizcaya Argentaria's ABMD Position: Q4 2022 in Review

Banco Bilbao Vizcaya Argentaria sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 997 shares — an estimated $245K sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ABMD in Q4 2019 and held it in 12 quarters. The position peaked at $1.76M in Q2 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 997 Abiomed Inc shares in Q4 2022, an estimated $245K.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Abiomed Inc in Q4 2019 and held it in 12 quarters.
  • Banco Bilbao Vizcaya Argentaria's Abiomed Inc position peaked at $1.76M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q4 2022, filed 13 Feb 2023.